Global Wound Closure Products Market to Rise at 6.3% CAGR from 2014-2023 with North America Leading the Way

Transparency Market Research has published a new research report about the global wound closure products market. The research report, titled “Wound Closure Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” discusses the future of this market, keeping in mind the historical data and the various trends and dynamics governing it. Furthermore, this research report offers an in-depth explanation of new wound closure products and the growth of this market in the coming years. According to the research report, the global wound closure products market was valued at US$8.8 bn in 2014 and is expected to reach US$15.2 bn in 2023, surging at a CAGR of 6.3% from 2014 to 2023.

Wound closure is an exceptionally important part of surgeries and treating injuries to prevent the occurrence of dangerous infections. Surgical complications or any other complications can lead to serious complications, which could further result in amputations of limbs. Owing to these reasons, medical practitioners give special importance to wound closure in terms of materials used for treating wounds and the methods in which they treated.

The global wound closure products market is segmented on the basis of type and geography. On the basis of type, the global wound closure products market is segmented into sutures, surgical staples, wound closure strips, adhesives and tissue sealants, and hemostats. Geographically, this market is segmented into Europe, North America, Asia Pacific, Latin America, and Rest of the World.

Out of all the types of wound closure products, adhesives and tissue sealants are popularly used due to their advantage of faster wound closure. This not only saves the patient’s time, but also reduces the number of revisits to the hospital for the dressing of stitches or their removal. The adhesives and tissue sealants segment is further sub-segmented into fibrin sealants, cyanoacrylate sealants, collagen-based sealants, albumin and glutaraldehyde based sealants, and polymer based sealants. The research analysts predict that the demand for adhesives and tissue sealants will go up due to the aforementioned benefits. Tissue sealants are used with sutures and staples in specific surgical procedures such as heart valve replacement surgery and bariatric surgery.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5429

Geographically, North America held a dominant share in the global wound closure products market. This region represented a share of 39.5% in the overall market, with Europe following the market leader closely. The introduction of new medical devices is expected to drive the growth of the wound closure products market in these two regions in the coming years.

Some of the key players operating in the global wound closure products market are B. Braun Melsungen AG, C. R. Bard, Inc., Baxter International Inc., Covidien plc, Ethicon (Johnson & Johnson), and CryoLife amongst others. The research report profiles these players to explain the competitive landscape present in the overall market. Furthermore, the research report also provides a comprehensive outlook of the research and development strategies being carried out by these players to gain a competitive advantage. For a holistic point of view on the global wound closure products market, the research report has provided a detailed assessment of the financial overview, business and marketing ideas, and strategic mergers and acquisitions of these top players in the overall market.

Breast Pumps Market: Challenges and Opportunities

Breast pumps refer to the medical devices regulated by the U.S. Food and Drug Administration (FDA) used by the lactating mothers to ensure uninterrupted milk supply to their infants when away from home. Breast pumps based on the mode of operation are classified into four major types namely manual, single electric, double electric and hospital grade breast pumps. Based on the design, there are two main types of breast pumps available; closed and open systems. Open systems do not contain a barrier between the milk collection kit and the pump tubing due to which collected milk is susceptible to contamination, while closed pumps prevent contamination due to the presence of a barrier between the collection kit and pump tubing. Currently, majority of the breast pumps available represent closed systems. Changing lifestyles and increasing number of women prioritizing their career along with their child, have emerged as the major factors impacting the growth of this market. On the other hand, high cost of the devices followed by risk of contamination might limit the market growth. Increasing disposable incomes of respective nations will further propel the market growth.

Recommendation of breast pumps is majorly dependent on the frequency of breastfeeding; Double electric breast pumps are the most preferred pumps for frequent breastfeeding as it ensures efficient milk expression with less time consumption. While single electric breast pumps are the most preferred pumps over manual pumps owing to powerful motor capacity and variable suction pressures. Hospital grade breast pumps are usually recommended in the initial phase of breastfeeding mainly to establish milk supply and get acquainted with the use of pumps. These pumps are by far the most superior types of breast pumps due to powerful motor, effective pumping capacity and can support multiple users. Distribution channel of personal grade breast pumps varies from hospital grade breast pumps; durable medical equipment (DME) supplier or retailer or online sales channel forms the base of personal grade breast pumps, while hospital grade pumps reaches to the end users via hospitals. Electric breast pumps are preferred over manual breast pumps due to several beneficial features such as electric motor support, effective milk expression and less time consumption.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=687

The global market for breast pumps is analyzed from two perspectives; product type and geography. Manual, single electric, double electric and hospital grade breast pumps are the four major product types. Single electric breast pumps market is the largest market in 2013 owing to the reasonable price and several benefits over the manual pumps. In terms of volume, manual breast pumps constitute the leading market segment owing to its low cost and easy availability. Double electric breast pumps market segment is anticipated to be the fastest growing segment owing to best option available after hospital grade breast pumps. This is attributed to certain features such as easy and efficient milk expression solution for mothers who have to express milk several times a day and on a daily basis. In addition, these pumps are available with adjustable suction cycles; they start with shorter but quicker sucks in order to accelerate the letdown response, followed by longer, deeper and slower sucks.

Geographically, breast pumps market is studied for four regions: North America, Europe, Asia Pacific and Rest of the World. These regions are further analyzed by country. In terms of Revenue, North America accounted for the largest market share in 2013, owing to increasing breastfeeding rates and increasing awareness about breastfeeding. In terms of volume, North America leads the breast pumps market. Key players operating in the global breast pumps market include Medela AG, Ameda AG, Pigeon Corporation, Royal Philips Electronics NV, NUK USA LLC and Lansinoh Laboratories, Inc.

Electric Handheld BP Devices Market Trends & Forecast up to 2019

Transparency Market Research, a leading provider of the latest market intelligence, has compiled a vast array of data on the medical devices industry over the years. The most recent research effort has been conducted under the title “Electric Handheld BP Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” All factors that are influencing the global electrical handheld BP devices market have been incorporated in this study.

According to the World Health Organization, in 2008, almost a billion people around the world were suffering from uncontrolled blood pressure issues. This had emerged as a major growth force for the global electrical handheld BP devices market, especially in the technological developments department. As it stands, there is a major need across the world for medical devices that are portable, easy to use, and minimally invasive.

One of the greatest drivers of the global electrical handheld BP devices market currently is the high prevalence of chronic diseases across the world. Blood pressure is one of the most common vitals that need to be regularly checked for patients of chronic diseases and therefore, the global electrical handheld BP devices market is expected to exhibit a high growth rate. Its growth rate will be directly proportional to the number of diagnoses of chronic diseases.

Other drivers of the global electrical handheld BP devices market include the increasing rate of awareness among patients regarding the modern devices available in this market and the various technological developments and innovations. One of the greater innovations is a reduction in the size of several electronic devices, which is making it possible for patients to easily carry the devices around.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1606

The leading region in terms of consumption as well as research and development efforts in the global electrical handheld BP devices market has been North America. This region is followed by Europe and then Asia Pacific, which is presenting rapid growth. The growth of Asia Pacific can be attributed to the high population density and the growing diagnosis rates of chronic disorders. One of the greatest market opportunities is being presented by the Latin America electrical handheld BP devices market owing to major steps taken by Brazil and Mexico in the healthcare industry.

The list of key players in the global electrical handheld BP devices market includes A & D Medical, Microlife, Mabis Healthcare, Inc., Medisana AG, Braun GmbH, American Diagnostic Corp, Welch Allyn, Omron Healthcare Co., Ltd., and Philips Healthcare.

Global Demand for Body Contouring Devices Market

A new study on the global body contouring devices market by Transparency Market Research (TMR) states that the increasing consciousness pertaining to one’s physical appearance has been fueling the demand for body contouring devices across the world over the last few years. The report is titled “Body Contouring Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

As per the study, the increasing prevalence of obesity among young individuals is anticipated to boost the worldwide body contouring devices market during the forecast period. However, the high cost associated with aesthetic procedures is likely to limit the growth of this market to some extent in the coming years.

The type of body contouring device and the regional distribution of the worldwide body contouring devices market have been taken as the main considerations for the analysis in this report. Based on the type of device, the study broadly classifies the market into the invasive devices segment, the minimally invasive devices segment, and the non-invasive devices segment.

The invasive devices segment includes ultrasound-assisted liposuction devices, the minimally invasive devices segment comprises radiofrequency assisted liposuction devices and laser assisted lipolysis devices, and the non-invasive devices segment consists of radiofrequency lipoplasty devices.

Geographically, the report has segmented the global body contouring devices market into Asia Pacific, Europe, North America, and the Rest of the World. North America holds the largest share in the overall market.

The increasing number of individuals concerned about their physical appearances is the key factor propelling this market in North America. A rise in the obese population is another significant driving force behind the growth of the North America body contouring devices market. Mexico has emerged as the leading domestic market for body contouring devices in this region, notes the research study.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1511

Analysts also project the body contouring devices markets in Europe and Asia Pacific to witness remarkable growth in their global share. While the increasing disposable income of people in developing economies such as China and India is likely to fuel the demand for these devices in Asia Pacific, the Europe body contouring devices market is expected to be driven by the easy availability of technically advanced devices.

An analysis of the competitive landscape prevalent in the global body contouring devices market has also been presented in this report. According to it, Syneron Medical Ltd., Palomar Medical Technologies, Valeant, Lumenis, Meridian Co. Ltd., Alma Lasers Ltd., and Cynosure are the leading producers of body contouring devices across the world.

Other significant companies operational in the worldwide market for body contouring devices are Andrew Technologies, BTL Industries, Cutera, GlobalMed Technologies, Human Med, Invasix Aesthetic Solutions, Misonix, VLCC Health Care Ltd., and YOLO Medicals, reports the research study.

Radiopharmaceuticals Market Witnesses Rising Demand and Investment from R&D Activities

Transparency Market Research has announced the release of a new market research report examining the global radiopharmaceuticals market. The report analyzes historical statistics concerning the market and dominant market trends affecting the dynamics and future alteration of the market. It breaks down the market by various criteria for a comprehensive understanding of the market and profiles major companies operating in the global radiopharmaceuticals market to provide an understanding of the competitive landscape of the market.The report, titled “Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”, puts the market statistics regarding radiopharmaceuticals under the microscope in a variety of ways. It analyzes the supply chain analysis of the global radiopharmaceuticals market to understand the dynamics of the market and examines the impact analysis of the various major factors that govern the market’s development both positively and negatively.

Thus, the report will help clients identify potential barriers and formulate market strategies keeping those in mind, indicate emerging and monopoly markets to invest in, and help conceptualize the development of total solutions.The report identifies the growing incidence of cancer and increasing preference for extremely specific remedies targeted at particular conditions as the major growth drivers for the global radiopharmaceuticals market. Cancer therapeutics involving radiopharmaceuticals are a major trend expected to propel the growth of the market thanks to the increased ease it offers to the patient, particularly in contrast with the conventional chemotherapy. In addition, increasing use of radiopharmaceuticals in molecular imaging is also helping the global radiopharmaceuticals market grow at a healthy rate.

The global radiopharmaceuticals market was worth US$3.8 billion in 2011 and is expected to be growing at a stupendous CAGR of 18.3% to reach a value of US$12.2 billion by 2018.This high growth rate is calculated taking into account various market restraints such as the stringent regulatory frameworks that regulate the storage and usage of radiopharmaceuticals all over the world, a global shortage of supply, and the strengthening threat from substitute treatments.The report categorizes the global radiopharmaceuticals market on the basis of the end user applying the radiopharmaceuticals, the application of the radiopharmaceuticals, and the geographical distribution of the global market. It also categorizes the radiopharmaceutical generator market on the basis of the radioactive isotope used in it.Mo-99/Tc-99m generators took up an overwhelmingly dominant share of the global radiopharmaceuticals market, leading other segments such as Sr-82/Rb-82 generators, Ge-68/Ga-67, 68 generators, Sr-90/Y-90 generators, and W-188/Re-188 generators.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213

“The technetium isotope Tc-99m has established marketing channels in the global market but the other segments are expected to make heavy inroads into the dominance of Tc-99m generators in the forecast period. In fact, all other segments of generators are expected to grow at double-digit CAGRs during the forecast period,” a TMR analyst said.

According to application, the global radiopharmaceuticals market is divided into the use of radiopharmaceuticals for diagnosis, which includes the techniques of SPECT and PET and has applications in oncology, cardiovascular disorders, and others such as neurology and gastrointestinal disorders; and the use of radiopharmaceuticals for therapy, inclusive of the various isotopes used in cancer treatment and the treatments used in other types of disorders such as cardiovascular and neurological. Oncology dominates the global market for radiopharmaceuticals comprehensively.

Epidermal Growth Factor Receptor Antibodies Market Outlook and Forecast up to 2023

The epidermal growth factor receptor (EGFR) is defined as a transmembrane tyrosine kinase receptor involved in the survival and proliferation of the cancerous cells. Any kind of mutations affecting these EFGR receptors or activity could results in cancer. Mutations lead to over-expresion resulting in large number of cancer, including lung cancer, anal cancer and glioblastoma multiforme. EGFR receptors are the first molecule target against which monoclonal antibodies (mAb) have been designed for cancer treatment. These monoclonal antibodies are sometimes also referred as EGFR antibodies. EGFR antibodies market can be segmented on the basis of the major antibodies which are used against EGFR receptors which include:

• Cetuximab
• Panitumumab
• Nimotuzumab

Cetuximab (erbitux) and panitumumab (vecitibix) are the most preferred biosimilar EGFR antibodies which are used for treatment of cancer. These antibodies have demonstrated efficacy in the treatment of colorectal cancer as single agents and in combination with conventional chemotherapy. Since the US Food and Drug Administration (FDA) had approved cetuximab in 2003 and panitumumab in 2006, EGFR antibodies have become primary step of treatment algorithms for colorectal cancer. However, nimotuzumab is a humanized monoclonal antibody that as of 2014 is recognized under orphan drugs status in the U.S. and the European Union for the treatment of glioma. This drug has also achieved marketing approval in India and China for squamaus cell carcinoma of the neck and head, and is currently undergoing numerous clinical trials.

Additionally, many market players and research institutions are performing research activities on development of the biosuperior EGFR antibodies against cancerous cells. The most common biosuperior EGFR antibodies include engineered EGFR antibodies, Bi- and Multi-specific EGFR antibodies and EGFR antibody drug conjugates. As for instance, Hoffmann-La Roche is performing a phase 1b study of MPDL3280A (and engineered antibody) in combination with Tarceva in patients suffering from non-small cell lung cancer. Such extensive research and development activities associated with the development of EGFR antibodies biosuperiors is the major factor which is driving this market. However, the high cost associated with research activities and sunk cost involved in R&D activities restrains the EGFR antibodies market.

Download Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7325

Moreover, the increasing incidence of cancer worldwide is also demanding for the more effective treatment methods, which is encouraging the researchers to develop EGFR antibodies. According to World Health Organization (WHO), cancer was the leading cause of death in 2012, accounting for 8.2 million deaths worldwide. Lung, liver, colorectal, stomach and breast cancers were responsible for most of the deaths every year. Statistics also revealed that breast cancer incidence had risen by more than 20% in 2012 from 2009, while breast cancer mortality rate has increased by 14%. Due to harsh lifestyle, excessive intake of alcohol and smoking habits, the incidence of cancer is increasing rapidly worldwide, especially in developed economies of North America and Europe. Increasing morbidity and mortality rate among the cancer patients is fuelling the demand for EGFR antibodies, hence driving the market.

Some of the market players which are actively contributing towards EGFR antibodies market include Amgen, Inc., Eisai, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Biocon Ltd., Takeda Pharmaceutical Company, Ltd. and Immunogen, Inc.

Increasing Popularity of Anti-Wrinkle Products to Fuel Asia, Europe, and South America Anti-Aging Market

According to a new market study published by Transparency Market Research, the Asia, Europe, and South America anti-aging market will log a CAGR of 9.3% from 2014 to 2020. As a result, the market’s valuation of US$15.28 bn in 2012 will increase to US$30.92 bn by 2020. The report, titled “Asia, Europe, and South America Anti-aging Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” is available for sale on the company’s website.

Aging is a natural phenomenon that occurs as a living being becomes older. Aging can refer to either a single cell in organisms or can refer to the population of a species. As more consumers lay increased emphasis on maintaining a youthful appearance, cosmetologists and healthcare experts are striving to find solutions to restore younger looks and defy the signs of aging.

Read Full Asia, Europe, and South America Anti-aging Market Report

Presently, the rising awareness among individuals to look healthy and beautiful is primarily driving the anti-aging market globally. Moreover, an increasing geriatric pool in Europe that gives high importance to younger looks and aesthetics is driving this regional market for anti-aging products and services. In addition, the increasing awareness about the signs of aging in generation X and generation Y is supporting growth of the anti-aging market.

The easy availability of a large number of products for varying anti-aging needs, which are also affordable, is also propelling the growth of the anti-aging market in Europe, South America, and Asia. On the other hand, the presence of a large number of players is preventing the emergence of a clear leader in the market and causing fragmentation in revenues.

On the basis of product, anti-wrinkle products represented the largest segment in Asia in 2013. The availability of a large range of anti-wrinkle products and rising awareness resulting from promotional campaigns are the primary factors fueling the demand for these products in Asia. Grey hair and wrinkles are among the most common signs of aging and start appearing around 30 years of age. As 40% of the Asian population falls within the 25 to 50 years bracket, the demand for anti-wrinkle products is steep in this region. Likewise, the anti-wrinkle product segment led the Europe anti-aging products market in 2013. This is mainly due to the high awareness among individuals about the availability of anti-wrinkle products marketed under various brand names.

Request For Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5021

In 2013, in Europe, laser aesthetic devices stood as the largest device segment due to their efficacy. Moreover, the permanent nature of laser procedures combined with an extensive demand for cost-effective portable devices augurs well for laser aesthetic devices. In 2013, laser aesthetic devices led the Asia ant-aging devices market as well. In the 2014-2020 period, the increasing obese population, higher demand for anti-cellulite devices due to their non-invasive nature, and preference for portable devices will fuel the growth of the laser aesthetic devices market.

Some of the top companies operating in the Asia, Europe, and South America market for anti-aging are Allergan Inc., Beiersdorf AG, Cynosure Inc., Lumenis Ltd., Personal Microderm, Alma Lasers Ltd., Coty Inc., L'Oreal SA, PhotoMedex Inc., and Solta Medical Inc.